Bioterrorism Threat Shines Spotlight on Drug Manufacturing

Published on: 
Pharmaceutical Technology, Pharmaceutical Technology-12-02-2001, Volume 25, Issue 12

Anthrax contamination has put pharmaceutical quality and supply issues on the front page, along with patent and pricing policies.

Related Content:

Quality SystemsRegulatory WatchPharmaceutical Technology-12-02-2001
Convergence in the Global Regulatory Village
The Punctuated Evolution of Computer Software Validation